Low-Pass Whole Genome Sequencing is a high-throughput molecular testing technology to analyze the entire genome at low coverage. It is a useful and accurate tool for the detection of copy number variations (CNVs), including gains (duplications) or losses (deletions) of large DNA segments. Some CNVs could contribute to certain genetic conditions.
Indications of LP-WGS testing include:
There are three types of LP-WGS sequencing results.
Result 1: Disease-causing variant(s) is found
Implication: The diagnosis of the disease being investigated is confirmed.
Result 2: No disease-causing variants is found
Implication: The diagnosis of the disease being investigated is not confirmed. It may be due to limitations of the current techniques or other unknown factor(s). Nevertheless, the result does not mean total exclusion of the diagnosis.
Result 3: Variant(s) of uncertain clinical significance is found:
Implication: A variant is found. With the latest medical genetic knowledge, it is still unclear whether this variant will result in any disease or is just benign polymorphism. In this circumstance, further genetic studies may be necessary, or genetic counselling and testing for the parent(s) or other family member(s) may be indicated. Despite that, it is still possible that a conclusion cannot be drawn in the end.
LP-WGS may possibly reveal incidental findings implicating diagnoses that are unrelated to the original indications of testing, including hereditary cancer syndrome, carrier status of autosomal recessive disorders, late onset neurological disorders, etc. Such results may potentially affect patient and/or family members in terms of insurance, job and academic application, psychological and social issues.
For further enquires, you may contact us.
Department of Clinical Genetics
Address: Specialist Outpatient Clinic, 1/F, Tower B, Hong Kong Children's Hospital, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong
Office Tel: 5741 3186
DCG-LPWGS
JUNE 2024